InvestorsHub Logo
Followers 7
Posts 98
Boards Moderated 0
Alias Born 06/09/2020

Re: EndoTarget post# 340065

Friday, 10/15/2021 6:33:09 PM

Friday, October 15, 2021 6:33:09 PM

Post# of 346054
I disagree, and I already laid out the math on why they don't need more capital. The Company is about to be a cash machine, generating >$100mm of EBITDA per year with minimal maintenance capital spending. Cash from operations alone can fund any new growth. Or, if something really big came along, they could easily go to 3-4x leverage on their EBITDA and raise $300mm+ in low cost debt.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News